Literature DB >> 8094035

Mutant p53 tumor suppressor gene causes resistance to transforming growth factor beta 1 in murine keratinocytes.

M Reiss1, V F Vellucci, Z L Zhou.   

Abstract

Human carcinoma cell lines are frequently refractory to the antiproliferative effect of the autocrine growth inhibitor transforming growth factor beta 1 (TGF-beta 1) and often express mutant forms of the tumor suppressor gene p53. Therefore, we wished to determine whether mutant p53 affects the cellular response to TGF-beta 1. A murine p53 complementary DNA carrying an activating point mutation was introduced into TGF-beta 1-sensitive BALB/MK mouse epidermal keratinocytes by retroviral infection. Mp53 transformed cells displayed a spindle-type morphology and expressed between 0.02 and 0.7 ng of mutant p53/mg total protein. Furthermore, whereas TGF-beta 1 caused approximately 90% maximal inhibition of DNA synthesis of parental BALB/MK cells, the Mp53 transformants were inhibited by less than 70%. The median inhibiting dose of TGF-beta 1 was 4.07 +/- 1 (SE) pM for BALB/MK cells, but ranged from 2.4 to 11.2 pM and from 11.7 to 40 pM for two different sets of Mp53 transformants, and increased as a function of the amounts of mutant p53 protein that were expressed. Our findings suggest that mutant forms of p53 inhibit the antiproliferative effect of TGF-beta 1 by interfering with its signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094035

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  16 in total

1.  Transforming growth factor β1 (TGF-β1) suppresses growth of B-cell lymphoma cells by p14(ARF)-dependent regulation of mutant p53.

Authors:  Gang Chen; Paritosh Ghosh; Thomas O'Farrell; Rachel Munk; Louis J Rezanka; Carl Y Sasaki; Dan L Longo
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

2.  Neural cell adhesion molecule L1 in gliomas: correlation with TGF-beta and p53.

Authors:  T Tsuzuki; S Izumoto; T Ohnishi; S Hiraga; N Arita; T Hayakawa
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

3.  neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice.

Authors:  B Li; J M Rosen; J McMenamin-Balano; W J Muller; A S Perkins
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

4.  Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells.

Authors:  T A McCaffrey; B Du; S Consigli; P Szabo; P J Bray; L Hartner; B B Weksler; T A Sanborn; G Bergman; H L Bush
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

5.  Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.

Authors:  T A McCaffrey; S Consigli; B Du; D J Falcone; T A Sanborn; A M Spokojny; H L Bush
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

6.  Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.

Authors:  Eyal Kalo; Yosef Buganim; Keren E Shapira; Hilla Besserglick; Naomi Goldfinger; Lilach Weisz; Perry Stambolsky; Yoav I Henis; Varda Rotter
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

7.  Resistance of human squamous carcinoma cells to transforming growth factor beta 1 is a recessive trait.

Authors:  M Reiss; T Muñoz-Antonia; J M Cowan; P C Wilkins; Z L Zhou; V F Vellucci
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer.

Authors:  Jonah Cohen; Zhong Chen; Shi-Long Lu; Xin Ping Yang; Pattatheyil Arun; Reza Ehsanian; Matthew S Brown; Hai Lu; Bin Yan; Oumou Diallo; Xiao-Jing Wang; Carter Van Waes
Journal:  Cancer Res       Date:  2009-04-07       Impact factor: 12.701

Review 9.  Transforming growth factor beta and the cell surface in tumor progression.

Authors:  M J Newman
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

10.  Human endometrial carcinoma cells release factors which inhibit the growth of normal epithelial cells in culture.

Authors:  C D Albright; G J Tsongalis; J H Resau; D G Kaufman
Journal:  Cell Biol Toxicol       Date:  1995-10       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.